The results reported below consist of overall NAFLD case-control GWAS and four additional case-only GWA quantitative studies for NAS score, fibrosis, and AST and ALT liver enzymes. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.